Effect of Early Management on PAin and DEpression in Patients With PancreatoBiliary Cancer, EPADE-PB
NCT01589328 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 288
Last updated 2018-01-03
Summary
Effect of Early management on PAin and DEpression in patients with PancreatoBiliary Cancer, EPADE-PB
Purpose
To determine whether early palliative care integrated with usual oncologic care with automated symptom monitoring can improve depression and pain in patients with cancer
Conditions
- Pancreatic Cancer
- Biliary Tract Cancer
- Cancer Pain
- Depression
Interventions
- OTHER
-
Early Palliative care integrated with usual oncologic care
Drug: The interventions consisted of the following: (1) Nursing assessment of pain and depression mood (2) Pain control based NCCN guideline (3) Depression control by psychoeducation and/or consultation of psychiatrist specialist (4) Patient education
Sponsors & Collaborators
-
National Cancer Center, Korea
lead OTHER_GOV
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-03-15
- Primary Completion
- 2017-06-30
- Completion
- 2017-06-30
Countries
- South Korea
Study Locations
More Related Trials
-
Analgesic Efficacy After Pancreatobiliary Surgery: Intravenous Versus Patient-controlled Epidural
NCT04352023 ·Status: UNKNOWN ·Phase: PHASE2
-
Anti-PD-1/PD-L1 Antibodies Plus Gemcitabine and Cisplatin for Advanced CCA
NCT07291063 ·Status: RECRUITING
-
Palliative Care in Improving Quality of Life in Patients With Newly Diagnosed Pancreatic Cancer
NCT02307539 ·Status: COMPLETED ·Phase: NA
-
Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer
NCT00049348 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of High Dose Radiation Therapy for Locally Advanced Pancreatic Cancer That Responded to Initial Chemotherapy Treatment
NCT06453486 ·Status: RECRUITING ·Phase: PHASE2
-
Ph 1B Trial With ADI-PEG 20 Plus Nab-Paclitaxel and Gemcitabine in Subjects With Pancreatic Cancer
NCT02101580 ·Status: COMPLETED ·Phase: PHASE1
-
A Longitudinal, Observational Biomarker Study in Pancreatic Cancer Patients Receiving Chemotherapy
NCT04281511 ·Status: COMPLETED
-
Pembrolizumab With Olaparib as Combined Therapy in Metastatic Pancreatic Cancer
NCT05093231 ·Status: RECRUITING ·Phase: PHASE2
-
Nurse-Provided Care or Standard Care in Treating Patients With Pancreatic Cancer
NCT00902733 ·Status: COMPLETED ·Phase: NA
-
Chemoradiotherapy With Gemcitabine/S-1 vs Gemcitabine/S-1 for Locally Advanced Pancreatic Cancer
NCT01430052 ·Status: COMPLETED ·Phase: PHASE2
-
A Single-Arm Study of Pembrolizumab With Gemcitabine and Cisplatin as Perioperative Therapy for Potentially Resectable Intrahepatic Cholangiocarcinoma
NCT05967182 ·Status: RECRUITING ·Phase: PHASE2
-
Web-based Treatment Information Tool for People With Advanced Pancreatic Cancer
NCT03632850 ·Status: COMPLETED
-
Combination of Anti-PD-1 Antibody and Chemotherapy in Pancreatic Cancer
NCT03983057 ·Status: COMPLETED ·Phase: PHASE2
-
Gemcitabine or Combination Chemotherapy Followed by Chemoradiation for Stage IB, II, or III Pancreatic Cancer
NCT00960284 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Multicenter Single-arm Prospective Clinical Study on First-line Treatment of Pancreatic Cancer Liver Metastases With Arterial Infusion Chemotherapy and Embolization Combined With Dual Immune Checkpoint Inhibitors.
NCT07333287 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Induction Chemotherapy With Gemcitabine and Cisplatin Followed by CCRT for Unresectable Pancreatic Carcinoma
NCT01593475 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer
NCT06282575 ·Status: RECRUITING ·Phase: PHASE3
-
Gemcitabine/Capecitabine Followed by SBRT in Pancreatic Adenocarcinoma
NCT01360593 ·Status: COMPLETED ·Phase: PHASE2
-
Pembrolizumab in Biliary Tract Cancer
NCT03260712 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase II Study to Assess the Efficacy and Safety of Preoperative Chemo With Radiation Therapy for Patients With Borderline Unresectable Adenocarcinoma of the Pancreas
NCT01240304 ·Status: TERMINATED ·Phase: PHASE2
-
Fixed Dose Rate Gemcitabine and Cisplatin Followed by Chemoradiation for Locally Advanced Pancreatic Cancer
NCT01396668 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Gemcitabine, Abraxane® Plus Placebo Versus Gemcitabine, Abraxane® Plus 1 or 2 Truncated Courses of Demcizumab in Subjects With 1st-Line Metastatic Pancreatic Ductal Adenocarcinoma
NCT02289898 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Pancreatic Cancer
NCT00026403 ·Status: COMPLETED ·Phase: PHASE2
-
Early Palliative Care for Patients With Advanced Pancreatic Cancer.
NCT04632303 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
M7824 Monotherapy in Locally Advanced or Metastatic Second Line (2L) Biliary Tract Cancer (Cholangiocarcinoma and Gallbladder Cancer)
NCT03833661 ·Status: COMPLETED ·Phase: PHASE2